U.S. markets closed

Calithera Biosciences, Inc. (CALA)

Other OTC - Other OTC Delayed Price. Currency in USD
0.02500.0000 (0.00%)
At close: 12:04PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0250
Bid0.0000 x 1100
Ask0.0000 x 1000
Day's Range0.0250 - 0.0250
52 Week Range0.0100 - 0.4999
Avg. Volume10,538
Market Cap122,056
Beta (5Y Monthly)-0.09
PE Ratio (TTM)N/A
EPS (TTM)-7.9400
Earnings DateMar 29, 2024 - Apr 02, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for CALA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Daily – Vickers Top Buyers & Sellers for 02/21/2024The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • GlobeNewswire

    Calithera Biosciences Announces Update on Complete Liquidation and Dissolution

    Special Meeting to be Held on or about June 29, 2023 with a Record Date of May 25, 2023SOUTH SAN FRANCISCO, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (OTC: CALA) (the “Company”) announced that it intends to hold a special meeting of stockholders on or about June 29, 2023 (the “Special Meeting”), for the purpose of approving the Company’s Plan of Complete Liquidation and Dissolution (the “Plan of Dissolution”). In January 2023, the Company announced its intention to com